Treatment of Hypercoagulation Syndrome with Anticoagulant Drug in Patients with Covid-19

Sabitkhodjaeva Saida Ulmasovna

Authors

Sabitkhodjaeva Saida Ulmasovna
[email protected]
Tashkent State Medical University, Tashkent, Uzbekistan

Vol. 2 No. 9 (2025): World of Medicine : Journal of Biomedical Sciences

Articles

September 27, 2025

Downloads

View Article

Abstract
How to Cite
Metrics

The paper presented the safety and efficacy of Rivaroxaban in the prevention of venous thromboembolism in hospitalized patients with COVID-19.

Ulmasovna, S. S. (2025). Treatment of Hypercoagulation Syndrome with Anticoagulant Drug in Patients with Covid-19. World of Medicine : Journal of Biomedical Sciences, 2(9), 36–40. Retrieved from https://wom.semanticjournals.org/index.php/biomed/article/view/505

Download Citation

World of Medicine : Journal of Biomedical Sciences

Treatment of Hypercoagulation Syndrome with Anticoagulant Drug in Patients with Covid-19

Authors

Downloads

MENU

counter

Information

^{Pemimpin Redaksi: Luiza Gabunia,}